Position in GRAL
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$14,832,476
+$3,036,206 QoQ
Shares Held
217,262
-4.8% QoQ
Ownership
0.486%
of shares outstanding
% of Portfolio
2.04%
of 13F equity value
Holder Rank
#28
of 373 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Slow Capital, Inc. holds $46,666,555 across 6 Diagnostics & Research names. GRAL ranks #1 (31.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GRAL |
GRAIL, Inc.
This page
|
217,262 | $14,832,476 | |
| 2 | ILMN |
Illumina, Inc.
|
48,067 | $8,451,620 | |
| 3 | GH |
Guardant Health, Inc.
|
52,547 | $7,883,626 | |
| 4 | MTD |
Mettler Toledo International Inc/
|
6,065 | $7,748,098 | |
| 5 | TMO |
Thermo Fisher Scientific Inc.
|
9,640 | $4,833,110 | |
| 6 | WGS |
GeneDx Holdings Corp.
|
42,500 | $2,917,625 |
All Filings in GRAL
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,832,476 | 217,262 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $11,796,270 | 228,256 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $13,901,271 | 162,417 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $8,505,259 | 143,840 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $7,344,832 | 142,840 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $3,472,341 | 135,957 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $2,379,119 | 133,284 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $1,215,723 | 88,352 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $169,454 | 11,025 | Shares | Sole | 2024-07-24 | |
| No filing history on record for this holder in this stock. | ||||||